Rheumatology
News
Latest data on COVID-19 patients with rheumatic diseases revealed in registry
Data for a total of 583 COVID-19 patients have now been made available.
News
Financial incentives affect the adoption of biosimilars
Adoption of infliximab biosimilars proceeded more slowly at an academic medical center than at a neighboring VAMC, where financial incentives to...
Latest News
Most e-consults not followed by specialist visit
The results reflect experts’ positive experiences with e-consults.
News
Infusion center directors shuffle treatment services in the era of COVID-19
“We look for ways to try to reassure patients and to comfort them, and work with them to make the best of the situation,” Dr. Christopher R....
News
Treatment for RA, SpA may not affect COVID-19 severity
A small study in Italy saw no apparent worsening of COVID-19 symptoms among people treated for RA or spondyloarthritis.
News
High and low trauma yield similar future osteoporotic fracture risk
A large cohort study shows similar links between low bone mineral density and future fractures, regardless of trauma.
News
Rheumatologists seek to reassure amid hydroxychloroquine shortage
Rheumatologists Jill P. Buyon and Peter M. Izmirly answer questions about the availability of hydroxychloroquine during the COVID-19 pandemic, and...
News
Stronger links forged between RA and asthma, COPD
Findings from the first-ever prospective study to evaluate asthma and COPD as risk factors for RA suggest providers should lower bar for...
Conference Coverage
Advances in ankylosing spondylitis hailed as rheumatology’s story of the year
MAUI, HAWAII – The likely approval of oral JAK inhibitors is predicted to transform the AS treatment paradigm.
Conference Coverage
Effective osteoarthritis therapy remains elusive
MAUI, HAWAII – ”The question is, have we really moved the needle in this disease in the last 30 years? The answer is I’m not so sure we have.” –...